{
  "title": "Wall Street Breakfast August 27: J&J Gains After Opioid Ruling",
  "author": "Seeking Alpha",
  "dc:creator": "Seeking Alpha",
  "enclosure": "",
  "guid": "4981ee9109f545a58b6cb8e3bb2261a0",
  "pubDate": "Tue, 27 Aug 2019 12:10:11 GMT",
  "link": "https://wall-street-breakfast.sounder.fm",
  "description": "<p>Our top stories today: J&J gains after opioid ruling; Morris-Altria merger talk makes the rounds; and AstraZeneca's Farxiga fast tracked.\nLearn more about your ad choices. Visit megaphone.fm/adchoices</p>",
  "content:encoded": "<p>Our top stories today: J&J gains after opioid ruling; Morris-Altria merger talk makes the rounds; and AstraZeneca's Farxiga fast tracked.\nLearn more about your ad choices. Visit megaphone.fm/adchoices</p>",
  "itunes:title": "Wall Street Breakfast August 27: J&J Gains After Opioid Ruling",
  "itunes:image": "",
  "itunes:author": "Seeking Alpha",
  "itunes:duration": "00:03:27",
  "itunes:explicit": false,
  "itunes:subtitle": "Our top stories today: J&J gains after opioid ruling; Morris-Altria merger talk makes the rounds; and AstraZeneca's Farxiga fast tracked.",
  "itunes:summary": "Our top stories today: J&amp;J gains after opioid ruling; Morris-Altria merger talk makes the rounds; and AstraZeneca's Farxiga fast tracked.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "itunes:episodeType": "full",
  "podcast:person": "Seeking Alpha",
  "podcast:transcript": "",
  "podcast:guid": "4981ee9109f545a58b6cb8e3bb2261a0"
}